about
Biochemical characterization of three BLT receptors in zebrafishCloning of adiponectin receptors that mediate antidiabetic metabolic effectsA G-protein-coupled receptor for leukotriene B4 that mediates chemotaxisCharacterization of an orphan G protein-coupled receptor, GPR20, that constitutively activates Gi proteinsCell-specific transcriptional regulation of human leukotriene B(4) receptor geneA second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disordersResolvin E1 inhibits dendritic cell migration in the skin and attenuates contact hypersensitivity responses.The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury.International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptorsThe lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivoPlexin-A1 and plexin-B1 specifically interact at their cytoplasmic domainsHydroxyeicosanoids bind to and activate the low affinity leukotriene B4 receptor, BLT2International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptorTwo distinct leukotriene B4 receptors, BLT1 and BLT2The role of leukotrienes in allergic diseasesG2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine12(S)-Hydroxyheptadeca-5Z, 8E, 10E-trienoic acid is a natural ligand for leukotriene B4 receptor 2Protective role of the leukotriene B4 receptor BLT2 in murine inflammatory colitisLeukotriene B4 receptor BLT2 negatively regulates allergic airway eosinophiliaBLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferationUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Cloning and characterization of rat leukotriene B(4) receptorCharacterization of the cloned guinea pig leukotriene B4 receptor: comparison to its human orthologueCharacterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distributionMast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axisRequirement of phosphatidylinositol 3-kinase activation and calcium influx for leukotriene B4-induced enzyme releaseInhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytesIdentification of a novel marker for dendritic cell maturation, mouse transmembrane protein 123Aromatic D-amino acids act as chemoattractant factors for human leukocytes through a G protein-coupled receptor, GPR109B12-Hydroxyheptadecatrienoic acid promotes epidermal wound healing by accelerating keratinocyte migration via the BLT2 receptorcDNA cloning and characterization of guinea-pig leukotriene B4 receptorInternational Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions.Leukotriene B4: metabolism and signal transduction.Thromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand.Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactionsCritical duration of intracellular Ca2+ response required for continuous translocation and activation of cytosolic phospholipase A2.Leukotriene B4 receptors.Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient miceThe absence of the leukotriene B4 receptor BLT1 attenuates peripheral inflammation and spinal nociceptive processing following intraplantar formalin injury.
P50
Q21131817-56974D18-85A6-46E3-901B-995D34497E09Q24304889-3A639496-DFBF-4977-BA11-28669EEE7281Q24308699-2FD61B8E-812B-4B28-B860-8C87E86C30E2Q24311977-8451809F-575D-47DA-A869-8A061A3D3375Q24676205-973EFC34-6355-446E-B30F-3CECAB51BFEAQ24676248-D538D5B2-2D20-4E60-9C6E-51058837406AQ27308761-CD66A23F-44F4-4E48-BDB5-79DBCFEE695FQ27863415-C3EACBD1-0F07-427F-BFA1-1082D279A515Q28180458-7DE2C26C-68A9-4707-997B-7A32CF1D99F6Q28200469-2BB38625-C31F-4666-A5B5-B49CDCABC317Q28206362-EC7209EA-86AB-4227-9DFF-4092605D5743Q28208437-5BDF9FE7-F715-468E-95DD-AF1DB0AF8C37Q28248531-DAEC9F64-2F8B-4E79-89A6-1B9305034D44Q28253421-AC5732C0-7C6B-438C-B3C7-CB48E688FEA1Q28255154-671BEE7A-ADAA-4E2D-A816-EC72AAB1B437Q28274505-8CE637FC-7AD8-4156-B8FE-1FC7A05C9A75Q28274624-3DCE1A92-D699-4857-B581-7F4AB7B3C77AQ28289126-1E87ACD0-ADAE-4B60-8578-41B1D0C13568Q28289322-61E9121F-28EC-44DC-A39C-F3AEFDDB4E83Q28293407-032E265A-CBC1-4391-85DD-6269030CE568Q28308192-CF0FB00A-9E43-4C09-A636-A64684845447Q28372088-175D9CEF-09E4-4340-B4A9-FFF5E5A4BBC2Q28373742-81A5BF24-4CC8-4019-9A79-F946825FA12FQ28507320-E5459D09-FC57-4EA7-BADB-8C3DB6F93012Q28510556-F2925659-BE0D-48B2-8023-63F4FBAF9DAEQ28571156-BC449487-404C-44AF-8F4F-1B8CDD6A9FC9Q28582315-2F0247D6-2CB2-43A1-89DB-1D73471A18C9Q28585521-3DC3F1FF-60C1-4AEF-BE7C-1CCA17E0EE30Q28586771-4EC6220A-551A-4491-B619-765EEF593628Q30486493-9CAE9042-C2F2-465C-ACAD-D0D19FD04F31Q30579732-0B7AB132-E4F2-420B-9AEE-2BD48B244615Q30749366-4872F3CC-B7EB-4065-BC17-3B975850C8FBQ34201977-ABE58E60-B5C5-4543-B78E-61E096AFF69EQ34257730-2C6191AC-6E32-4E0E-ABB2-89517337BF28Q34368967-042CDDA0-F295-4044-BC5C-8D1F0E6A7272Q34565310-5F8C88A6-7FCD-414A-9EDB-750166D6B5A2Q34756757-52DD92FA-589D-4EA9-B411-6B54C4FAAF4CQ34998035-D124DDAA-D4A1-4B27-93B7-936F66359B18Q35088319-DC502AEA-0908-4BCC-9AE7-FC2718354337Q35186247-01A7D2C8-3396-443F-B85B-E70EB2A9D7A5
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Takehiko Yokomizo
@ast
Takehiko Yokomizo
@en
Takehiko Yokomizo
@es
Takehiko Yokomizo
@nl
Takehiko Yokomizo
@sl
type
label
Takehiko Yokomizo
@ast
Takehiko Yokomizo
@en
Takehiko Yokomizo
@es
Takehiko Yokomizo
@nl
Takehiko Yokomizo
@sl
prefLabel
Takehiko Yokomizo
@ast
Takehiko Yokomizo
@en
Takehiko Yokomizo
@es
Takehiko Yokomizo
@nl
Takehiko Yokomizo
@sl
P1053
P-5673-2016
P106
P1153
7004400566
P21
P31
P3829
P496
0000-0002-5219-1553
P569
2000-01-01T00:00:00Z